Macy's, Inc. (M) stock
Close on Oct 30, 2026Market cap $6.30BP/E 8.8Yield 3.03%
Earnings
Macy's's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Macy's's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2026ended Nov 1, 2026 | Dec 2, 2026Expected | – | – | – | – | – |
| Q2 FY2026ended Aug 1, 2026 | Sep 10, 2026before the open | $4.90B | +2.1% | $0.62 | $0.63 | Release |
| Q1 FY2026ended May 2, 2026 | Jun 3, 2026before the open | $4.70B | +2.2% | $0.23 | $0.13 | Release |
| Q4 FY2025ended Jan 31, 2026 | Mar 18, 2026before the open | $7.60B | -2.6% | $1.84 | $1.67 | Release |
| Q3 FY2025ended Nov 1, 2025 | Dec 3, 2025before the open | $4.70B | 0.0% | $0.04 | $0.09 | Release |
| Q2 FY2025ended Aug 2, 2025 | Sep 3, 2025before the open | $4.80B | -2.0% | $0.31 | $0.41 | Release |
| Q1 FY2025ended May 3, 2025 | May 28, 2025before the open | $4.60B | -4.2% | $0.13 | $0.16 | Release |
| Q4 FY2024ended Feb 1, 2025 | Mar 6, 2025before the open | $7.80B | -3.7% | $1.21 | $1.80 | Release |
| Q3 FY2024ended Nov 2, 2024 | Dec 11, 2024before the open | $4.70B | -6.7% | $0.10 | $0.04 | Release |
| Q2 FY2024ended Aug 3, 2024 | Aug 21, 2024before the open | $4.90B | -4.5% | $0.53 | $0.53 | Release |
| Q1 FY2024ended May 4, 2024 | May 21, 2024before the open | $4.80B | -4.0% | $0.22 | $0.27 | Release |
| Q4 FY2023ended Feb 3, 2024 | Feb 27, 2024before the open | $8.10B | -2.4% | -$0.26 | $2.45 | Release |
| Q3 FY2023ended Oct 28, 2023 | Nov 16, 2023before the open | $5.04B | -3.1% | $0.15 | $0.21 | Release |
| Q2 FY2023ended Jul 29, 2023 | Aug 22, 2023before the open | $5.13B | -8.4% | -$0.08 | $0.26 | Release |
| Q1 FY2023ended Apr 29, 2023 | Jun 1, 2023before the open | $5.00B | -6.5% | $0.56 | $0.56 | Release |
| Q4 FY2022ended Jan 28, 2023 | Mar 2, 2023before the open | $8.30B | -4.2% | $1.83 | $1.88 | Release |
| Q3 FY2022ended Oct 29, 2022 | Nov 17, 2022before the open | $5.20B | -4.4% | $0.39 | $0.52 | Release |
| Q2 FY2022ended Jul 30, 2022 | Aug 23, 2022before the open | $5.60B | – | $0.99 | $1.00 | Release |
| Q1 FY2022ended Apr 30, 2022 | May 26, 2022before the open | $5.35B | – | $0.98 | $1.08 | Release |
| Q4 FY2021ended Jan 29, 2022 | Feb 22, 2022before the open | $8.67B | – | $2.44 | $2.45 | Release |
| Q3 FY2021ended Oct 30, 2021 | Nov 18, 2021before the open | $5.44B | – | $0.76 | $1.23 | Release |
| Q2 FY2021ended Jul 31, 2021 | Aug 19, 2021before the open | – | – | – | – | Release |
| Q1 FY2021ended May 1, 2021 | May 18, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Jan 30, 2021 | Feb 23, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Oct 31, 2020 | Nov 19, 2020before the open | – | – | – | – | Filing |
| Q2 FY2020ended Aug 1, 2020 | Sep 2, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Macy's's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net sales | FY2026 | $21.68B – $21.83B | $21.50B – $21.75B | Raised | Sep 10, 2026 |
| Comparable sales change | FY2026 | +1% – +1.5% | +0.5% – +1.2% | Raised | Sep 10, 2026 |
| Adjusted EBITDA as a percent of total revenuenon-GAAP | FY2026 | 7.7% – 7.9% | – | New | Jun 3, 2026 |
| Adjusted diluted EPSnon-GAAP | FY2026 | $2.15 – $2.35 | $2.00 – $2.20 | Raised | Sep 10, 2026 |
| Adjusted EBITDA as a percent of total revenuenon-GAAP | FY2026 | 7.8% – 8% | – | New | Sep 10, 2026 |
Guidance vs results
The last range Macy's gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Adjusted diluted earnings per share | $2.00 – $2.20 | $2.33Σ4Q | Above range |
| FY2025 | Revenue | $21.48B – $21.63B | $21.70BΣ4Q | Above range |
Guidance history
Every forecast Macy's put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Sep 10, 2026 | Comparable sales change | FY2026 | +1% – +1.5% | Raised |
| Sep 10, 2026 | Adjusted diluted EPS | FY2026 | $2.15 – $2.35 | Raised |
| Sep 10, 2026 | Adjusted EBITDA as a percent of total revenue | FY2026 | 7.8% – 8% | New |
| Sep 10, 2026 | Net sales | FY2026 | $21.68B – $21.83B | Raised |
| Jun 3, 2026 | Comparable sales change | FY2026 | +0.5% – +1.2% | New |
| Jun 3, 2026 | Adjusted EBITDA as a percent of total revenue | FY2026 | 7.7% – 7.9% | New |
| Jun 3, 2026 | Adjusted diluted EPS | FY2026 | $2.00 – $2.20 | New |
| Jun 3, 2026 | Net sales | FY2026 | $21.50B – $21.75B | New |
| Dec 3, 2025 | Comparable owned-plus-licensed-plus-marketplace sales change | FY2025 | 0% – +0.5% | New |
| Dec 3, 2025 | Adjusted EBITDA as a percent of total revenue | FY2025 | 7.8% – 8% | New |
| Dec 3, 2025 | Core Adjusted EBITDA as a percent of total revenue | FY2025 | 7.5% – 7.8% | Lowered |
| Dec 3, 2025 | Adjusted diluted earnings per share | FY2025 | $2.00 – $2.20 | New |
| Dec 3, 2025 | Net sales | FY2025 | $21.48B – $21.63B | New |
| Sep 3, 2025 | Comparable owned-plus-licensed-plus-marketplace sales change | FY2025 | -1.5% – -0.5% | Raised |
| Sep 3, 2025 | Adjusted diluted earnings per share | FY2025 | $1.70 – $2.05 | Raised |
| Sep 3, 2025 | Net sales | FY2025 | $21.15B – $21.45B | New |
| May 28, 2025 | Comparable owned-plus-licensed-plus-marketplace sales change | FY2025 | -2% – -0.5% | Reaffirmed |
| May 28, 2025 | Adjusted EBITDA as a percent of total revenue | FY2025 | 7.4% – 7.9% | Lowered |
| May 28, 2025 | Core Adjusted EBITDA as a percent of total revenue | FY2025 | 7% – 7.5% | Lowered |
| May 28, 2025 | Adjusted diluted earnings per share** | FY2025 | $1.60 – $2.00 | Lowered |
| May 28, 2025 | Net sales* | FY2025 | $21.00B – $21.40B | Reaffirmed |
| Mar 6, 2025 | Comparable owned-plus-licensed-plus-marketplace sales change | FY2025 | -2% – -0.5% | New |
| Mar 6, 2025 | Adjusted EBITDA as a percent of total revenue | FY2025 | 8.4% – 8.6% | New |
| Mar 6, 2025 | Core Adjusted EBITDA as a percent of total revenue | FY2025 | 8% – 8.2% | Lowered |
| Mar 6, 2025 | Adjusted diluted earnings per share | FY2025 | $2.05 – $2.25 | New |
| Mar 6, 2025 | Net sales | FY2025 | $21.00B – $21.40B | New |
| Dec 11, 2024 | Adjusted EBITDA 1 as a percent of total revenue | FY2024 | 8% – 8.4% | New |
| Dec 11, 2024 | Adjusted diluted earnings per share | FY2024 | $2.25 – $2.50 | Lowered |
| Dec 11, 2024 | Gross margin rate | FY2024 | 38.2% – 38.3% | New |
| Dec 11, 2024 | Net sales | FY2024 | $22.30B – $22.50B | Raised |
| Aug 21, 2024 | Comparable owned-plus-licensed-plus-marketplace sales change (52 week basis) | FY2024 | -2% – -0.5% | Lowered |
| Aug 21, 2024 | Adjusted diluted earnings per share | FY2024 | $2.55 – $2.90 | Reaffirmed |
| Aug 21, 2024 | Net sales | FY2024 | $22.10B – $22.40B | Lowered |
| May 21, 2024 | Comparable owned-plus-licensed-plus-marketplace sales change (52 week basis) | FY2024 | -1% – +1.5% | Raised |
| May 21, 2024 | Adjusted diluted earnings per share | FY2024 | $2.55 – $2.90 | Raised |
| May 21, 2024 | Net sales | FY2024 | $22.30B – $22.90B | Raised |
| Feb 27, 2024 | Comparable owned plus licensed plus marketplace sales change (52 week basis for both 2024 and 2023) | FY2024 | -1.5% – +1.5% | New |
| Feb 27, 2024 | Adjusted diluted earnings per share | FY2024 | $2.45 – $2.85 | New |
| Feb 27, 2024 | Net sales | FY2024 | $22.20B – $22.90B | New |
| Nov 16, 2023 | Comparable owned-plus-licensed sales change (52 week basis) | FY2023 | -7% – -6% | Raised |
| Nov 16, 2023 | Adjusted diluted earnings per share* | FY2023 | $2.88 – $3.13 | Narrowed |
| Nov 16, 2023 | Net sales | FY2023 | $22.90B – $23.20B | Raised |
| Aug 22, 2023 | Comparable owned-plus-licensed sales change (52 week basis) | FY2023 | -7.5% – -6% | Reaffirmed |
| Aug 22, 2023 | Adjusted diluted earnings per share* | FY2023 | $2.70 – $3.20 | Reaffirmed |
| Aug 22, 2023 | Net sales | FY2023 | $22.80B – $23.20B | Reaffirmed |
| Jun 1, 2023 | Comparable owned-plus-licensed sales change (52 week basis) | FY2023 | -7.5% – -6% | Lowered |
| Jun 1, 2023 | Adjusted diluted earnings per share | FY2023 | $2.70 – $3.20 | Lowered |
| Jun 1, 2023 | Net sales | FY2023 | $22.80B – $23.20B | Lowered |
| Mar 2, 2023 | Comparable owned plus licensed sales change (52 week basis) | FY2023 | -4% – -2% | New |
| Mar 2, 2023 | Adjusted diluted earnings per share | FY2023 | $3.67 – $4.11 | New |
| Mar 2, 2023 | Net sales | FY2023 | $23.70B – $24.20B | New |
| Nov 17, 2022 | Adjusted EBITDA as a percent of sales | FY2022 | 10.5% | Reaffirmed |
| Nov 17, 2022 | Adjusted diluted earnings per share | FY2022 | $4.07 – $4.27 | Raised |
| Nov 17, 2022 | Net sales | FY2022 | $24.34B – $24.58B | Reaffirmed |
| Aug 23, 2022 | Adjusted EBITDA as a percent of sales | FY2022 | 10.5% | Lowered |
| Aug 23, 2022 | Adjusted diluted earnings per share* | FY2022 | $4.00 – $4.20 | Lowered |
| Aug 23, 2022 | Net sales | FY2022 | $24.34B – $24.58B | Lowered |
| May 26, 2022 | Adjusted EBITDA as a percent of sales | FY2022 | 11.2% – 11.7% | Raised |
| May 26, 2022 | Adjusted diluted earnings per share (reflecting first quarter share repurchases) | FY2022 | $4.53 – $4.95 | Raised |
| May 26, 2022 | Net sales | FY2022 | $24.46B – $24.70B | Reaffirmed |
| Feb 22, 2022 | Comparable owned plus licensed sales three-year CAGR* | FY2022 | +1.1% – +1.4% | New |
| Feb 22, 2022 | Adjusted EBITDA as a percent of sales | FY2022 | 11% – 11.5% | New |
| Feb 22, 2022 | Adjusted diluted earnings per share | FY2022 | $4.13 – $4.52 | New |
| Feb 22, 2022 | Net sales | FY2022 | $24.46B – $24.70B | New |
| Nov 18, 2021 | comparable sales on an owned-plus-licensed basis versus 2019 | Q4 FY2021 | +2% – +4% | New |
| Nov 18, 2021 | Adjusted EBITDA as a percent of sales | FY2021 | 12.5% | New |
| Nov 18, 2021 | Adjusted diluted earnings per share | FY2021 | $4.57 – $4.76 | New |
| Nov 18, 2021 | Net sales | FY2021 | $24.12B – $24.28B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Macy's filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- Results
- Results
- Results
- News
- News
- News
- News
- Results
- Update
- Results
- Update